Profil
David J.
Daly's current job is as the Chief Executive Officer at Exai Bio, Inc. Formerly, Mr. Daly served as the Co-Chief Executive Officer & Director at Thrive Earlier Detection Corp.
from 2019 to 2021.
He also worked as the Director-US Sales-Animal Health Division at Abbott Laboratories.
Additionally, he held the position of Independent Director at NeoGenomics, Inc. from 2021 to 2023.
Mr. Daly was the Chief Commercial Officer & Senior Vice President at Clarient, Inc. from 2005 to 2012.
He also served as the SVP & General Manager-Commercial Operations at Illumina, Inc. from 2017 to 2019.
Furthermore, he worked as the Area Marketing Manager at Roche Diagnostics Corp.
and as the Vice President-Commercial Operations at Thermo Fisher Scientific, Inc. in 2014.
From 2014 to 2017, Mr. Daly held the position of Chief Commercial Officer & GM-Clinical Oncology at Foundation Medicine, Inc. He was also the President & Chief Operating Officer at Singular Genomics Systems, Inc. from 2021 to 2022.
Mr. Daly completed his undergraduate degree at the University of California, Irvine, and his graduate degree at the University of California, Santa Barbara.
Aktive Positionen von David Daly
| Unternehmen | Position | Beginn |
|---|---|---|
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Develops a ribonucleic acid-based liquid biopsy platform for early cancer detection | Vorstandsvorsitzender | 24.07.2024 |
Ehemalige bekannte Positionen von David Daly
| Unternehmen | Position | Ende |
|---|---|---|
| NEOGENOMICS, INC. | Direktor/Vorstandsmitglied | 19.01.2023 |
| SINGULAR GENOMICS SYSTEMS, INC. | Präsident | 03.06.2022 |
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Develops liquid biopsy test that is designed to detect cancers at early stages | Vorstandsvorsitzender | 01.01.2021 |
| ILLUMINA, INC. | Corporate Officer/Principal | 01.08.2019 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | 11.08.2017 |
Ausbildung von David Daly
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Clarient, Inc.
Clarient, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnostic testing services | Health Services |
NeoGenomics, Inc.
NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services | Health Services |
Illumina, Inc.
Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Health Technology |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Foundation Medicine, Inc.
Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Singular Genomics Systems, Inc.
Singular Genomics Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Develops scalable spatial multiomics technology for precision diagnostics and personalized medicine | Commercial Services |
Thrive Earlier Detection Corp.
Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Develops liquid biopsy test that is designed to detect cancers at early stages | Health Technology |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Develops a ribonucleic acid-based liquid biopsy platform for early cancer detection | Technology Services |
















